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Abstract
Purpose The aim of this study was to compare the outcomes of right hemicolectomywith CME performed with laparoscopic and
open surgery.
Methods PubMed, Scopus, Web of Science, China National Knowledge Infrastructure, Wanfang Data, Google Scholar and the
ClinicalTrials.gov register were searched. Primary outcome was the overall number of harvested lymph nodes. Secondary
outcomes were short and long-term course variables. A meta-analysis was performed to calculate risk ratios.
Results Twenty-one studies were identified with 5038 patients enrolled. The difference in number of harvested lymph nodes was
not statistically significant (MD 0.68, − 0.41–1.76, P = 0.22). The only RCT shows a significant advantage in favour of
laparoscopy (MD 3.30, 95% CI − 0.20–6.40, P = 0.04). The analysis of CCTs showed an advantage in favour of
the laparoscopic group, but the result was not statically significantly (MD − 0.55, 95% CI − 0.57–1.67, P = 0.33).
The overall incidence of local recurrence was not different between the groups, while systemic recurrence at 5 years
was lower in laparoscopic group. Laparoscopy showed better short-term outcomes including overall complications,
lower estimated blood loss, lower wound infections and shorter hospital stay, despite a longer operative time. The
rate of anastomotic and chyle leak was similar in the two groups.
Conclusions Despite the several limitations of this study, we found that the median number of lymph node harvested in the
laparoscopic group is not different compared to open surgery. Laparoscopy was associated with a lower incidence of systemic
recurrence.
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Introduction
Colorectal cancer (CRC) is one of the most common health-
threatening diseases around the globe. It is the third most
frequent cancer worldwide (1.85 million new cases/year,
representing 10.2% of total malignancies) and, according to
predictions, is expected to increase in incidence by a further
20% before 2030 [1]. The number of annual worldwide deaths
from CRC was approximately 880,000 in 2018, with an in-
creasing trend year on year [2].
The prognosis of this disease is strongly related to the stage
at the time of diagnosis, with a 5-year survival rate of around
90%when the cancer is diagnosed at an early stage, compared
with 13% when the presentation is delayed and metastatic
disease is present [2]. In particular, lymph node involvement
determines important variations in outcome, with overall 5-
year CRC survival at 59% [3]. Patients with stage II and stage
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III CRC treated with potentially curative surgery will still
sadly die of the disease in up to 30% of cases at 5 years. At
least part of this may be determined by understaging of
the disease due to an insufficient lymph node yield [4],
as this factor is important in determining subsequent
oncologic adjuvant treatment [5].
Surgery is the mainstay of potentially curative treatment,
also playing a central role in staging. Standard segmental
colectomy with D2 lymphadenectomy is based on the onco-
logical principle that local control of disease determines sur-
vival, with lymphadenectomy mainly meant for prognosis
rather than cure [6]. In fact, the indication for adjuvant che-
motherapy is based on several factors, including nodal status,
and may provide a reduction in mortality by up to 30%.
According to guidelines [7], a minimum of 12 lymph
nodes should be analysed for an accurate staging of the
disease, whilst an understaging may result in patients
not receiving adjuvant therapy.
It is in this context that in 2009 Hohenberger proposed to
extend the lymphadenectomy, describing complete mesocolic
excision (CME) for the treatment of cancer of the caecum and
ascending colon [8]. In subsequent years, the technique
spread, and it was later adapted to laparoscopy which had
become the accepted standard of care in the surgical treatment
of colon cancer. The aim of this systematic review and meta-
analysis is to compare short-term and long-term outcomes of
individuals with right colon cancer undergoing treatment by
open or laparoscopic right hemicolectomy with CME.
Materials and methods
We performed a systematic review of the literature, which was
searched up to 20 March 2020, according to the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) guidelines [9], including the following databases:
Medline/PubMed, Scopus, Web of Science (WOS), China
National Knowledge Infrastructure (CNKI, 中国知网),
Wanfang Data (万方)) and Google Scholar.
The following search statement was used in Medline/
PubMed:
& (“laparoscopy”[MeSH Terms] OR “laparoscopy”[All
Fields] OR “laparoscopic”[All Fields]) AND (“Vet
Surg”[Journal] OR “vs”[All Fields]) AND open[All
Fields] AND right[All Fields] AND CME[All Fields]
(“laparoscopy”[MeSH Terms] OR “laparoscopy”[All
Fields] OR “laparoscopic”[All Fields]) AND (“Vet
Surg”[Journal] OR “vs”[All Fields]) AND open[All
Fields] AND complete[All Fields] AND mesocolic[All
Fields] AND excision[All Fields]
& (“laparoscopy”[MeSH Terms] OR “laparoscopy”[All
Fields] OR “laparoscopic”[All Fields]) AND CME[All
Fields] AND open[All Fields] AND right[All Fields]
AND (“colectomy”[MeSH Terms] OR “colectomy”[All
Fields])
& (“laparoscopy”[MeSH Terms] OR “laparoscopy”[All
Fields] OR “laparoscopic”[All Fields]) AND open[All
Fields] AND central[All Fields] AND (“blood
vessels”[MeSH Terms] OR (“blood”[All Fields] AND
“vessels”[All Fields]) OR “blood vessels”[All Fields]
OR “vascular”[All Fields]) AND (“ligation”[MeSH
Terms] OR “ligation”[All Fields]) AND right[All Fields]
AND (“colectomy”[MeSH Terms] OR “colectomy”[All
Fields])
In the other databases (WOS, Scopus, CNKI and Wanfang
Data), the search was performed by entering the association of
the following keywords:
& laparoscopic AND open AND right AND colectomy
& laparoscopic AND CME AND open AND right AND
colectomy
& laparoscopic AND complete mesocolic excision AND
open AND right AND colectomy
A further search was performed through the reference lists
of the selected articles and relevant grey literature on Google
Scholar. Finally, ClinicalTrials.gov was searched to evaluate
any ongoing registered clinical trials.
Eligibility criteria
Studies that compared participants enrolled for either laparo-
scopic or open right hemicolectomy with CME were
eligible for inclusion. Randomized controlled trials
(RCTs) and clinical control studies (CCTs) (prospective
and retrospective cohort studies) were included. Case
report studies were excluded.
Study selection and data extraction
Two reviewers (RC and SZ) performed the search indepen-
dently. A third author (AA) arbitrated any disagreements on
inclusion or exclusion of studies. The reference lists of
the included studies were searched manually. Only the
data for patients who had undergone open or laparo-
scopic CME were included.
Outcomes of interest
Primary outcome was the overall number of harvested lymph
nodes. Secondary outcomes were local and systemic recur-
rence at 3 and 5 years, operative time, post-operative mortality
at 30 days, overall post-operative complications at 30 days,
estimated blood loss, surgical intraoperative complications
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(vascular injuries, iatrogenic small bowel perforation), anasto-
motic leak rate, chyle leak rate, post-operative hospital stay,
post-operative ileus, wound infections and pulmonary
infections.
Quality assessment
All studies fulfilling the selection criteria for this systematic
review and meta-analysis were assessed for methodological
quality and risk of bias by two authors (RC and GA). The
individual scores of quality assessment items per study were
assessed using the Cochrane risk tool for Randomised Control
Trials [10, 11] and the methodological index for non-
randomised studies (MINORS) [12].
Statistical analyses
All analyses were performed according to original treatment
allocation (intention-to-treat analysis). The categorical vari-
ables were described as absolute/relative frequencies and the
continuous ones asmedian and interquartile range (IQR). Data
were analysed for risk ratios (RR) in the case of dichotomous
variables, and weighted mean differences (WMD) for contin-
uous variables. The randomisedMantel-Haenszel method was
used for the meta-analysis. All results were displayed in Forest
plots. The I2 and the Cochrane’s Q were reported as statistical
measures of heterogeneity. For outcomes with more than ten
studies, funnel plots are shown. Other statistical measures of
bias are not reported given the high study heterogeneity. The
data analysis was performed using the meta-analysis software
ReviewManager (RevMan) v 5.3.5 (Copenhagen: The Nordic
Cochrane Centre, The Cochrane Collaboration, 2018).
In this meta-analysis, a subgroup analysis according to the
types of study design was performed. We also identified the
studies which had both the largest variance (wide intervals)
and the extreme outlier weight in each clinical outcome group.
Results
Study selection
The PRISMA flow diagram is presented in Fig. 1. The initial
search produced 2055 studies. After removal of duplicates,
721 citations remained. After screening of titles and abstracts,
36 studies were analysed in full text, with 12 studies excluded
as reported in SDC1, leaving 23 studies matching the inclu-
sion criteria for meta-analysis [13–47], one PhD thesis by El
Nakeeb (not published) [13]. Of these, two references [15, 16]
report the same data as well as the PhD thesis [13]. In addition,
we found one ongoing study (registered in ClinicalTrials.gov
as NCT03826446) [48].
Altogether, the 21 studies included provided data on 5038
patients (Table 1). The included studies were published
Fig. 1 Prisma flow chart of
literature search
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between 2010 and 2020, with participants enrolled between
2000 [19, 34] and 2019 [13, 15] (Table 1).
Study characteristics
There were one RCT, performed at Menoufia University
(Egypt) [15, 16] and 20 CCTs [14, 17–35]. Sixteen studies
were performed in Asia (4601 patients, 91.3%), including 13
from China (2158 patients), 2 from South Korea (2419 pa-
tients) and 1 from Bangladesh (24 patients). Three studies
were performed in Europe (377 patients, 7.5%), including 2
in Russia (102 patients) and 1 in Germany (279 patients). One
study was performed in Egypt (Africa) (60 patients, 1.2%).
Pooled trials were comparable for age, gender, BMI (body
mass index), ASA (American Society of Anesthesiology)
and TNM stage (SDC 2). Inclusion and exclusion criteria were
mostly well reported but varied considerably between studies.
Among the examined studies, patients with stage IV
disease were excluded, except for one [18]. The other
studies include stages I, II and III, but two [14, 25]
only included stage III cancers and two [22, 26] only
included stages II and III; in addition, five studies [15,
28–30, 32] do not indicate the TNM stage.
Concerning tumour localisation, all of the studies consid-
ered cancers of cecum, ascending colon and hepatic flexure,
while only five studies [17, 20, 22, 31, 32] also included
proximal transverse colonic neoplasms.
For what it concerns conversion from laparoscopic to open
resection, most of the studies excluded the patients which
required this procedure for any reason. From those other stud-
ies that considered in their data also converted surgeries, we
excluded the converted procedures in our analysis.
Quality assessment
We assessed the risk of bias for each trial and summarised
them using the criteria and the ‘Risk of bias’ Table (SDC 3).
No data were reported on random sequence generation or
allocation concealment in the RCT, while blinding of partici-
pants and personnel was not reported. A ‘low risk of bias’was
reported in the analysis of the attrition bias and an ‘unclear risk
of bias’ for selective reporting. Risks of bias assessed with the
Table 1 Inclusion criteria
Author–year of publication Nation Type of study No. of patients included Time of enrolment Type of access No. of patients for access
(laparosopic/open)
Wang 2020 China R 280 2010–2015 LA (M)-OA 160 120
Menoufia
University
Elbalshy 2019 Egypt RCT 60 2016–2019 LA (M)-OA 30 30
El Fol 2019
Jin 2019 China R 153 2011–2015 LA (M)-OA 71 82
Pelz 2018 Germany R 279 2009–2016 LA (M)-OA 24 255
Shin 2018 South Korea P 2249 2000–2013 LA (M)-OA 1010 1239
Yu 2018 China R 218 2010–2014 LA (M)-OA 102 116
Li 2018 China R 88 2012–2015 LA (M)-OA 40 48
Aiypov 2018 Russia R 59 NR LA (M)-OA 11 48
Rasulov 2017 Russia P 39 2015–2016 LA (M)-OA 22 17
Chen 2017 China R 82 2011–2012 LA (M)-OA 27 55
Mondal 2017 Bangladesh P 24 2015–2017 LA (M)-OA 14 10
Huang 2015 China R 102 2012–2013 LA (M)-OA 53 49
Yin 2015 China R 267 2010–2014 LA (M)-OA 75 192
Liu 2015 China R 84 2011–2012 LA (M)-OA 44 40
Gao 2015 China R 55 2010–2014 LA (M)-OA 18 37
Zhao G 2014 China R 46 2010–2013 LA (M)-OA 24 22
Cong 2014 China R 178 2008–2011 LA (M)-OA 96 82
Bae 2014 South Korea R 170 2006–2008 LA (M)-OA 85 85
Zhao L 2014 China R 220 2006–2009 LA (M)-OA 119 101
Han 2014 China R 324 2003–2010 LA (M)-OA 177 147
Guan 2010 China R 61 2006–2010 LA (M)-OA 29 32
Type of study: RCT, randomized control study; R, observational retrospective; P, observational prospective
Type of approach: LA, laparoscopic assisted; OA, open access; M: multiport
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MINORS scale quality assessment for non-RCTs is reported
in SDC 4. The mean score was 16 (moderate risk).
Primary outcome
The overall number of harvested lymph nodes was reported in
3876 patients (19 studies) [14, 15, 17–21, 24–35]. The num-
ber of nodes was higher in the laparoscopic group, but the
difference was not statistically significant (MD 0.68, − 0.41–
1.76, P = 0.22, I2 = 90%).
The analysis of the RCT performed from Menoufia
University (Egypt) shows a significant advantage in favour
of laparoscopy (MD 3.30, 95% CI − 0.20–6.40, P = 0.04).
However, the analysis of CCTs showed an advantage in fa-
vour of the laparoscopic group, but not statically significant
(MD 0.55, 95% CI − 0.57–1.67, P = 0.33, I2 = 90%) (Fig. 2).
Secondary outcomes
Overall recurrence at 3 years was reported in 3 studies [14, 16,
24] (n = 414). The incidence of overall recurrence was signif-
icantly lower in the laparoscopic group (RR 0.55, 95% CI
0.34 to 0.91, P = 0.02, I2 = 0%) (SDC 5).
Overall recurrence at 5 years was reported in 3 studies [19,
31, 33] (n = 1860). The incidence of overall recurrence was
significantly lower in the laparoscopic group (RR 0.61, 95%
CI 0.48 to 0.77, P = < 0.0001, I2 = 0%) (SDC 6).
Local recurrence at 3 years was reported in 3 studies [14,
16, 24] (n = 414). The overall incidence of local recurrence
was significantly lower in the laparoscopic group (RR 0.60,
95% CI 0.38 to 0.95, P = 0.03, I2 = 0%) (SDC 7).
Local recurrence at 5 years was reported in 4 CCTs [19, 29,
31, 33] (n = 1944). The overall incidence of local recurrence
was not different between the groups (RR − 0.55, 95%CI 0.20
to 1.54, P = 0.26, I2 = 54%) (SDC 8).
Systemic recurrence at 3 years was reported in 2 CCTs [14,
24] (n = 354). The overall incidence of systemic recurrence
was not different between the groups (RR 1.13, 95% CI
0.31–4.11, P = 0.85, I2 = 0%) (SDC 9).
Systemic recurrence at 5 years was reported in 3 CCTs [19,
31, 33] (n = 1860). The overall incidence of systemic recur-
rence was significantly lower in laparoscopic group (RR 0.53,
95% CI 0.39–0.72, P = 0.001, I2 = 28%) (SDC 10).
Twenty studies [14, 16, 17, 19–24, 26–28, 30–35]
reported operative time (3768 patients). This was signif-
icantly longer in the laparoscopic group compared to
open surgery (MD − 23.26, 95% CI − 16.17 to −
30.75, P < 0.00001; I2 = 94%) (Fig. 3).
Nine studies [16, 19, 21, 22, 24, 27, 31–33] reported post-
operative mortality at 30 days (n = 2471). No statistically sig-
nificant difference was observed between the two groups (RR
0.53, 95% CI 0.13–2.11, P = 0.37, I2 = 0%) (SDC 11).
Intraoperative blood loss was reported in 13 studies [14,
16, 17, 20, 24, 26–29, 31, 33–35] (2139 patients). The
Fig. 2 Forest plot of comparison: Laparoscopic versus open CME right hemicolectomy. Overall number of harvested lymph nodes
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estimated blood loss was statistically significantly lower in the
laparoscopic group compared with the open group (MD −
41.42, 95% CI − 52.22 to − 27.62, I2 = 95%) (Fig. 4).
Four studies [23, 25, 32, 33] reported on surgical
intraoperative complications (vascular injuries, iatrogenic
small bowel perforation) (607 patients). These were
lower in the open (0.36%, 1/275) than in the laparo-
scopic group (1.2%, 4/332), but the result was not sta-
tistically significant (RR 1.72, 95% CI 0.38 to 7.85;
I2 = 0%) (SDC 12).
Fig. 3 Forest plot of comparison: Laparoscopic versus open CME right hemicolectomy. Operative time
Fig. 4 Forest plot of comparison: Laparoscopic versus open CME right hemicolectomy. Intraoperative blood loss
1614 Int J Colorectal Dis (2021) 36:1609–1620
Twelve studies [16, 17, 19–21, 24, 27, 28, 30–33] reported
post-operative complications at 30 days (2991 patients).
These were significantly lower in the laparoscopic group
(RR 0.83, 95% CI 0.71–0.97, P = 0.02, I2 = 0%) (SDC 13).
Anastomotic leak (AL) was reported in 15 studies [14, 15,
17, 19–22, 24, 26–28, 30–33] (3614 patients). No statistically
significant difference was observed between the two groups
(RR 0.81, 95% CI 0.48–1.35, P = 0.47, I2 = 0%) (Fig. 5).
Nine studies [17, 20, 24–26, 28, 30, 31, 33], all CCTs,
reported on rates of chyle leak (n = 1293). These did not differ
between groups (RR 1.08, 95% CI 0.47–2.48, P = 0.86, I2 =
20%) (Fig. 6).
Six studies [17, 20, 24, 28, 30, 34], all CCTs, reported post-
operative hospital stay (n = 821). This was significantly lower
in the laparoscopic group compared to the open group (MD −
2.68, 95% CI − 4.10–1.26, P = 0.0002, I2 = 92%) (SDC 14).
Ten studies [16, 17, 19–21, 24, 26, 28, 31, 33] reported on
post-operative ileus (n = 2906). No statistically significant dif-
ference was observed between the two groups (RR 1.05, 95%
CI 0.76–1.44, P = 0.79, I2 = 0%) (SDC 15).
Eigth studies [16, 17, 21, 24, 26, 28, 31, 33] reported on
post-operative wound infections (n = 1322). These were sig-
nificantly fewer in the laparoscopic group compared to the
open group (RR 0.41, 95% CI 0.22–0.79, P = 0.007, I2 =
0%) (SDC 16).
Four studies [14, 21, 24, 33] reported pulmonary infections
(n = 774). No statistically significant difference was observed
between the two groups (RR 0.50, 95% CI 0.50–1.70, P =
0.27, I2 = 46%) (SDC 17).
Discussion
The CME technique as part of a right hemicolectomy is
technically difficult because of the large variability in the
right colon vasculature, which may be the cause of chal-
lenging intraoperative bleeding complications. Moreover,
CME should be performed by surgeons with a significant
experience in colorectal surgery. It is important to recall
that the localisation of the disease influences the extent of
lymphadenectomy in the peripancreatic area: for experts
of the CME technique, cancers located in the hepatic flex-
ure and in proximal transverse colon require extension to
the Henle trunk stations.
Several authors have published their data and results
in the execution of CME in a laparoscopic setting,
which clearly requires further experience in advanced
laparoscopic surgery. The choice between laparoscopy
or open surgery for CME remains a point of discussion
and interest. Moreover, some argue that CME may be
Fig. 5 Forest plot of comparison: Laparoscopic versus open CME right hemicolectomy. Anastomotic leak
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an appropriate indication for a robotic approach [49,
50], and further data are required to assess the utility
of robotics in this setting.
We compared laparoscopic and open CME in terms of the
number of lymph nodes harvested. Moreover, we evaluated the
differences in long-term prognosis considering the 3-year and 5-
year post-operative overall survival and disease-free survival.
Local control of the disease is improved by an increased number
of harvested lymph nodes [7]. The samples of patients were
comparable for age, gender, BMI, ASA and TNM stage. In
addition, despite the majority of the studies indicated the TNM
stage, the exact localisation of primary tumour was often not
reported. This clearly represents a limit in the literature available
regarding this topic. Finally, raw data or hazard ratios of survival
curves, both overall and disease-free, would be more useful to
understand the true equivalence of laparoscopic and open tech-
niques in terms of oncologic outcome. During the entire analysis,
a significant heterogeneity was often observed, so that we pre-
ferred to use, as standard, random effects. For these reasons, we
would need an Individual Patient Database (IPD) or, at least, the
hazard ratios of the published studies.
Laparoscopic CME may allow more lymph nodes to be har-
vested than in open surgery. Nevertheless, laparoscopy appeared
superior to open surgery in terms of overall recurrence at 3 and 5
years, the only measurable parameter related to oncologic ade-
quacy. However, there needs to be caution in interpretation of
this result due to the possible influence of selection bias.
Improved staging of the disease does allow patients to be
considered for the most appropriate therapeutic approach, in
particular the receipt of adjuvant chemotherapy. Han et al.
[33] also showed how laparoscopy resulted in an increased
harvested number of so-called principal lymph nodes (along
the course of the superior mesenteric artery), this, being more
radical, and possibly aided by the improved magnification of
the surgical field offered by laparoscopy.
Besides extended lymphadenectomy, CME requires the
mesocolic fascia to be excised intact, in order to guarantee
advantages in term of oncological radicality and survival [8,
51–53]. In our systematic review and meta-analysis, we did
not report data about the quality of the surgical specimen,
since only five studies [20, 23, 26, 28, 30], among those in-
cluded, explicitly reported this feature. In fact, most of the
authors, although describing in detail the technique used and
highlighting the importance of the integrity of the mesocolon,
focused their attention on the number of harvested lymph
nodes in order to evaluate the local control of the disease.
This bias could derive from low initial experience of patholo-
gists in the examination of the mesocolic fascia, in a similar
way that happened at the beginning of the application of total
mesorectal excision (TME) for rectal cancer. However, it re-
mains technically imperative to maintain the integrity of the
mesocolic fascia during CME in order to maximise appropri-
ate oncological radicality.
It is important to remember that laparoscopic approachmay
fail and require conversion to open surgery because of various
reasons: the main factor that implicates conversion is a vascu-
lar injury that leads to uncontrollable bleeding or that cannot
be detected in its source; other conditions that could require
the change of procedure could be the excess of adhesions or an
organ injury hard to repair laparoscopically. In case of con-
version to the open approach, there are consequences for the
patient that must be considered and discussed before choosing
this method: in particular, the outcome of the patient worsens
in term of longer and complicated post-operative stay, the
possible need for post-operative ICU and longer operative
time. These complications are a direct consequence of the
conversion and are not a consequence of the open technique,
that is why it is very important to select the patients that will
undergo laparoscopic surgery [54, 55].
The presented data show laparoscopy to be at least non infe-
rior to open surgery when performing CME for cancer of the
right colon, with other benefits of a minimally invasive approach
also confirmed. Moreover, the laparoscopy group resulted in a
lower 5-year systemic recurrence rate, even if this outcome was
reported by only a few studies: the results might be considered
promising but will need further confirmation by the enlargement
Fig. 6 Forest plot of comparison: Laparoscopic versus open CME right hemicolectomy. Chylous leak
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of the cohort of studies. Laparoscopy offered better short-term
outcomes including overall complications, lower estimated blood
loss and lower wound infection rates, altogether translating into a
shorter hospital stay. This appears at the expense of a longer
operative time, likely due to the higher technical difficulty asso-
ciated with the surgery, in particular when a laparoscopic extend-
ed right hemicolectomy is performed for tumours located at the
hepatic flexure or proximal transverse colon. These endpoints are
similar to other meta-analyses [37, 38] regarding this topic, and a
possible explanation is that the laparoscopic technique is harder
to perform and requires a longer learning curve. No difference
was observed in terms of post-operative mortality, anastomotic
leak, chylous leak or pulmonary infection, which is reassuring.
The current study has several limitations. Although this
systematic review included the highest number of studies re-
ported in literature, the major limitation is represented by the
geographical distribution of the studies. In fact, all but one
studies which was performed in Germany [18] were published
by non-western groups: 16 studies were from Asia (13 from
China, 2 from South Korea and 1 from Bangladesh), 1 from
Africa (Egypt) and 2 East Europe (Russia). The importance of
this limitation is related to the possibility of differences not
only in surgical standards but also in standards of adjuvant
therapy and health care systems, difficult to assess. A second
limitation is that among these studies only one is an RCT.
Therefore, the meta-analysis is based on non randomised con-
trolled trials. It would have been interesting to perform a sub-
group analysis for TNM/UICC stage associated with the rate
of laparoscopic and open surgery, in order to assess possible
advantages of laparoscopy in terms of recurrence for a specific
tumour stage which requires adjuvant chemotherapy. A third
limitation is the impossibility to assess and meta-analyse the
data regarding the number of cases in which the minimum of
12 lymph nodes were harvested, corresponding to current
guidelines [7]. In order to achieve both these analyses, prob-
ably an Individual Participant Database analysis should be
planned. Furthermore, it is likely that the control group (open
surgery) is often not treated by a well-trained surgeon, being
the operation time quite long (median 173 min). Finally, de-
spite Hohenberger [8] recommended a minimum of 25 lymph
nodes harvested, the overall median in the open group is only
21.8, with 5 papers reporting even a median of 15 or less.
Another developing field in the group of minimally in-
vasive techniques is robotic surgery: some studies [56, 57]
analysed the feasibility, safety and effectiveness of robotic
CME, which could be considered as another possible tech-
nique to assist CME and having potential for improving the
outcomes and quality of life of patients, such as many
studies also suggest for laparoscopic procedures as com-
pared to traditional open surgery [58, 59]. However, data
are still missing, and the number of studies needs to be
increased in order to evaluate this alternative minimally
invasive approach.
In conclusion, the present systematic review and meta-
analysis fails to show that a laparoscopic approach appears
non-inferior to open surgery in terms of lymph nodes harvest-
ed but showed a benefit in terms of incidence of systemic
recurrence, when performing right hemicolectomy with
CME for colon cancer, while maintaining the usual benefits
of a minimally invasive surgical approach.
Nevertheless, further prospective and randomised studies
are awaited to increase the quantity of data and quality of the
evidence.
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